The benefits and risks of testosterone replacement therapy: a review

References

• NieschlagESwerdloffRBehreHMInvestigation, treatment and monitoring of late-onset hypogonadism in malesAging Male20058565816096159
   PubMedGoogle Scholar
• MoralesASchulmanCCTostainJWuFCWTestosterone deficiency syndrome (TDS) needs to be named appropriately – the importance of accurate terminologyEur Urol20065040740916854520
   PubMed Web of Science ®Google Scholar
• RhodenELMorgentalerARisks of testosterone-replacement therapy and recommendations for monitoringN Engl J Med2004350548249214749457
   PubMed Web of Science ®Google Scholar
• HarmanSMMetterEJTobinJDPearsonJBlackmanMRBaltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy menJ Clin Endocrinol Metab20018672473111158037
   PubMed Web of Science ®Google Scholar
• DingELSongYMalikVSLiuSSex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysisJAMA20062951288129916537739
   PubMed Web of Science ®Google Scholar
• LaughlinGABarrett-ConnorEBergstromJLow serum testosterone and mortality in older menJ Clin Endocrinol Metab200893687517911176
   PubMed Web of Science ®Google Scholar
• LaaksonenDENiskanenLPunnonenKTestosterone and sex hormone binding globulin predict the metabolic syndrome and diabetes in middle-aged menDiabetes Care2004271036104115111517
   PubMed Web of Science ®Google Scholar
• KhawKTDowsettMFolkerdEEndogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population StudyCirculation20074116232694270118040028
   PubMed Web of Science ®Google Scholar
• ShoresMMMatsumotoAMSloanKLKivlahanDRLow serum testosterone and mortality in male veteransArch Intern Med20061661660166516908801
   PubMed Web of Science ®Google Scholar
• AraujoAKupelianVPageSTHandelsmanDJBremnerWJMcKinlayJBSex steroids and all-cause mortality and cause-specific mortality in menArch Intern Med20071671252126017592098
   PubMed Web of Science ®Google Scholar
• LindemanRDYauCLBaumgartnerRNMorleyJEGarryPJNew Mexico Aging Process Study. Longitudinal study of fasting serum glucose concentrations in healthy elderly. The New Mexico Aging Process StudyJ Nutr Health Aging20037317217712766795
   PubMedGoogle Scholar
• VermeulenAAndrogen replacement therapy in the aging male – a critical evaluationJ Clin Endocrinol Metab200186238039011397827
   PubMed Web of Science ®Google Scholar
• BhasinSBuckwalterJGTestosterone supplementation in older men: a rational idea whose time has not yet comeJ Androl20012271873111545281
   PubMedGoogle Scholar
• FeldmanHALongcopeCDerbyCAAge trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging StudyJ Clin Endocrinol Metab20028758959811836290
   PubMed Web of Science ®Google Scholar
• LiuPYBeilinJMeierCNguyenTVCenterJRLeedmanPJAge-related changes in serum testosterone and sex hormone binding globulin in Australian men: longitudinal analyses of two geographically separate regional cohortsJ Clin Endocrinol Metab2007923599360317595245
   PubMed Web of Science ®Google Scholar
• OrwollELambertLCMarshallLMTestosterone and estradiol in older menJ Clin Endocrinol Metab2006911336134416368750
   PubMed Web of Science ®Google Scholar
• YeapBBAlmeidaOPHydeZIn men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health in Men StudyEur J Endocrinol200715658559417468195
   PubMed Web of Science ®Google Scholar
• KrithivasKYurgalevitchSMMohrBAEvidence that the CAG repeat in the androgen receptor is associated with age related decline in serum androgens levels in menJ Endocrinol199916213714210396030
   PubMed Web of Science ®Google Scholar
• ZmudaJMCauleyJAKriskaAGlynnNWGutaiJPKullerLHLongitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle age men: a 13 year follow-up of former Multiple Risk Factors Intervention Trial participantsAm J Epidemiol199746609617
   Google Scholar
• GrayAFeldmanHAMcKinlayJBLongcopeCAge, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging StudyJ Clin Endocrinol Metab199173101610251719016
   PubMed Web of Science ®Google Scholar
• AraujoABEscheGRKupelianVPrevalence of symptomatic androgen deficiency in menJ Clin Endocrinol Metab2007924241424717698901
   PubMed Web of Science ®Google Scholar
• WuFCWTajarAPyeSRHypothalamic–pituitary–testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: The European Male Aging StudyJ Clin Endocrinol Metab2008932737274518270261
   PubMed Web of Science ®Google Scholar
• VeldhuisJDAging and hormones of the hypothalamo–pituitary axis: gonadotropic axis in men and somatotropic axes in men and womenAgeing Res Rev2008718920818343203
   PubMed Web of Science ®Google Scholar
• KaufmanJMVermeulenAThe decline of androgen levels in elderly men and its clinical and therapeutic implicationsEndocr Rev20052683387615901667
   PubMed Web of Science ®Google Scholar
• MoralesASpevackMEmersonLAdding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistryAging Male200710576517558969
   PubMed Web of Science ®Google Scholar
• BhasinSCunninghamGRHayesFJTestosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guidelineJ Clin Endocrinol Metab2006911995201016720669
   PubMed Web of Science ®Google Scholar
• SchiaviRCSchreiner-EngelPWhiteDMandeliJThe relationship between pituitary-gonadal function and sexual behavior in healthy aging menPsychosom Med1991533633741924649
   PubMed Web of Science ®Google Scholar
• TravisonTGMorleyJEAraujoABO’DonnellABMcKinlayJBThe relationship between libido and testosterone levels in aging menJ Clin Endocrinol Metab2006912509251316670164
   PubMed Web of Science ®Google Scholar
• MorleyJEKimMJHarenMTKevorkianRBanksWAFrailty and the aging maleAging Male2005813514016390735
   PubMed Web of Science ®Google Scholar
• BaumNCandaceACrespiCATestosterone replacement in elderly men. Testosterone replacement in elderly menGeriatrics2007621518
   PubMed Web of Science ®Google Scholar
• ShoresMMMoceriVMSloanKLMatsumotoAMKivlahanDRLow testosterone levels predict incident depressive illness in older men: effects of age and medical morbidityJ Clin Pyschiatry200566714
   PubMed Web of Science ®Google Scholar
• LunenfeldBSaadFHoeslCEISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationaleAging Male20058597416096160
   PubMedGoogle Scholar
• MorleyJEBaumgartnerRNRoubenoffRMayerJNairKSSarcopeniaJ Lab Clin Med200113723124311283518
   PubMed Web of Science ®Google Scholar
• ZitzmannMFaberSNieschlagEAssociation of specific symptoms and metabolic risks with serum testosterone in older menJ Clin Endocrinol Metab2006914335434316926258
   PubMed Web of Science ®Google Scholar
• MorleyJECharltonEPatrickPValidation of a screening questionnaire for androgen deficiency in aging malesMetabolism2000491239124211016912
   PubMed Web of Science ®Google Scholar
• MorleyJEPerryHMIIIKevorkianRTPatrickPComparison of screening questionnaires for the diagnosis of hypogonadismMaturitas20065342442916140484
   PubMed Web of Science ®Google Scholar
• HeinemannLASaadFHeinemannKThaiDMCan results of the Aging Males’ Symptoms (AMS) scale predict those of screening scales for androgen deficiencyAging Male2004721121815669540
   PubMedGoogle Scholar
• MooreCHueblerDZimmermannTHeinemannLASaadFThaiDMThe Aging Males’ Symptoms scale (AMS) as outcome measure for treatment of androgen deficiencyEur Urol200446808715183551
   PubMed Web of Science ®Google Scholar
• T’SjoenGGoemaereSDe MeyereMKaufmanJMPerception of males’ aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levelsPsychoneuroendocrinology20042920121414604601
   PubMed Web of Science ®Google Scholar
• KelleherSConwayAJHandelsmanDJBlood testosterone threshold for androgen deficiency symptomsJ Clin Endocrinol Metab2004893813381715292310
   PubMed Web of Science ®Google Scholar
• IsidoriAMGiannettaEGianfrilliDEffects of testosterone on sexual function in men: results of a meta-analysisClin Endocrinol200563601602
   PubMed Web of Science ®Google Scholar
• MorleyJEMelmedSGonadal dysfunction in systematic disordersMetabolism19792810511073386028
   PubMed Web of Science ®Google Scholar
• MatsumotoAMAndropause: Clinical implications of the decline in serum testosterone levels with aging in menJ Gerontol Med Sci2002577699
   PubMed Web of Science ®Google Scholar
• DiverMJImtiazKEAhmadAMVoraJPFraserWDDiurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young menClin Endocrinol (Oxf)20035871071712780747
   PubMed Web of Science ®Google Scholar
• WangCNieschlagESwerdloffRInvestigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendationsEur J Endocrinol200815950751418955511
   PubMed Web of Science ®Google Scholar
• CitronJTEttingerBRubinoffHPrevalence of hypothalamic-pituitary imaging abnormalities in impotent men with secondary hypogonadismJ Urol19961555295338558653
   PubMed Web of Science ®Google Scholar
• BunchTJAbrahamDWangSMeikleAWPituitary radiographic abnormalities and clinical correlates of hypogonadism in elderly males presenting with erectile dysfunctionAging Male20025384612040974
   PubMedGoogle Scholar
• RhodenELEstradaCLevineLMorgentalerAThe value of pituitary magnetic resonance imaging in men with hypogonadismJ Urol200317079579812913700
   PubMed Web of Science ®Google Scholar
• BuvatJLemaireAEndocrine screening in 1, 022 men with erectile dysfunction clinical significance and cost effective strategyJ Urol1997158176417679334596
   PubMed Web of Science ®Google Scholar
• AraujoABO’DonnellABrambillaDJPrevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging StudyJ Clin Endocrinol Metab2004895920592615579737
   PubMed Web of Science ®Google Scholar
• VermeulenAHormonal cut-offs of partial androgen deficiency: a survey of androgen assaysJ Endocrinol Invest200528283116042357
   PubMedGoogle Scholar
• van den BeldAWde JongFHGrobbeeDEPolsHALambertsSWMeasures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly menJ Clin Endocrinol Metab2000853276328210999822
   PubMed Web of Science ®Google Scholar
• RosnerWAuchusRJAzzizRSlussPMRaffHUtility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statementJ Clin Endocrinol Metab2007924051317090633
   PubMed Web of Science ®Google Scholar
• VermeulenAVerdonckLKaufmanJMA critical evaluation of simple methods for the estimation of free testosterone in serumJ Clin Endocrinol Metab1999843666367210523012
   PubMed Web of Science ®Google Scholar
• WangCPlymateSNieschlagEPaulsenCASalivary testosterone in men: further evidence of a direct correlation with free serum testosteroneJ Clin Endocrinol Metab198153102110247197285
   PubMed Web of Science ®Google Scholar
• MorleyJEPerryHMIIIPatrickPDollbaumCMKellsJMValidation of salivary testosterone as a screening test for male hypogonadismAging Male2006916516917050116
   PubMed Web of Science ®Google Scholar
• GonacharovNKatsyaGDobrachevaANizhnikAKolesnikovaGHerbstVWestermannJDiagnostic significance of free salivary testosterone measurement using a direct luminescence immunoassay in healthy men and in patients with disorders of androgenic statusAging Male2006911112216916746
   PubMed Web of Science ®Google Scholar
• CalofOMSinghABLeeMLAdverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trialsJ Gerontol A Biol Sci Med Sci2005601451145716339333
   PubMed Web of Science ®Google Scholar
• ParsonsJKCarterHBPlatzEAWrightEJLandisPMetterEJSerum testosterone and the risk of prostate cancer: potential implications for testosterone therapyCancer Epidemiol Biomarkers Prev2005142257226016172240
   PubMed Web of Science ®Google Scholar
• ZitzmannMNieschlagEAndrogen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal menJ Clin Endocrinol Metab2007923844385317635942
   PubMed Web of Science ®Google Scholar
• VelazquezIAlterBPAndrogens and liver tumors: Fanconi’s anemia and non-Fanconi’s conditionsAm J Hematol200477325726715495253
   PubMed Web of Science ®Google Scholar
• ImamotoTSuzukiHFukasawaSPretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomyEurUrol200547308312
   Google Scholar
• McClureRDOsesRErnestMLHypogonadal impotence treated by transdermal testosteroneUrology19913732242000678
   PubMed Web of Science ®Google Scholar
• BhasinSBremnerWJEmerging issues in androgen replacement therapyJ Clin Endocrinol Metab199782388989221
   PubMed Web of Science ®Google Scholar
• ComhaireFHAndropause: hormone replacement therapy in the aging maleEurUrol200038655662
   Google Scholar
• Von EckardsteinNieschlagETreatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II studyJ Androl200223341942512002444
   PubMedGoogle Scholar
• WangCSwerdloffRSIranmaneshATransdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal menJ Clin Endocrinol Metab2000852839285310946892
   PubMed Web of Science ®Google Scholar
• YuZGuptaSKHwangSSTestosterone pharmacokinetics after application of an investigational transdermal system in hypogonadal menJ Clin Pharmacol199737113911459506009
   PubMed Web of Science ®Google Scholar
• KimMKZhaoHLeeCHKimDDFormulation of a reservoir-type testosterone transdermal delivery systemInt J Pharm20012191–2515911337165
   PubMed Web of Science ®Google Scholar
• McNicholasTADeanJDMulderHCarnegieCJonesNAA novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual functionBJU Int200391697412614254
   PubMed Web of Science ®Google Scholar
• SalehianBWangCAlexanderGPharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: comparison to testosterone enanthate – a clinical research center studyJ Clin Endocrinol Metab199580356735758530600
   PubMed Web of Science ®Google Scholar
• KorbonitsMSlawikMCullenDRossRJA comparison of a novel testosterone bioadhesive buccal system, striant, with a testosterone adhesive patch in hypogonadal malesJ Clin Endocrinol Metab2004892039204315126518
   PubMed Web of Science ®Google Scholar
• RossCNFrenchJAPateraKJIntensity of aggressive interactions modulates testosterone in male marmosetsPhysiol Behav200483343744515581666
   PubMed Web of Science ®Google Scholar
• WangCSwerdloffRKipnesMMatsumotoAMNew testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal menJ Clin Endocrinol Metab2004893821382915292312
   PubMed Web of Science ®Google Scholar
• JockenhovelFVogelEKreutzerMReinhardtWLederbogenSReinweinDPharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal menClin Endocrinol1996456171
   PubMed Web of Science ®Google Scholar
• KelleherSConwayAJHandelsmanDJInfluence of implantation site and track geometry on the extrusion rate and pharmacology of testosterone implantsClin Endocrinol200155531536
   PubMed Web of Science ®Google Scholar
• HandelsmanDJClinical pharmacology of testosterone pellet implantsNieschlagEBehreHMTestosterone action deficiency substitution2nd edBerlinSpringer-Verlag1998349364
   Google Scholar
• LyngdorfPHemmingsenLEpidemiology of erectile dysfunction and its risk factors: a practice-based study in DenmarkInt J Impot Res20041610511114973529
   PubMed Web of Science ®Google Scholar
• SelvinEBurnettALPlatzEAPrevalence and risk factors for erectile dysfunction in the USAm J Med200712015115717275456
   PubMed Web of Science ®Google Scholar
• SchiaviRCSchreiner-EngelPWhiteDMandeliJPituitary-gonadal function during sleep in men with hypoactive sexual desire and in normal controlsPsychosomat Med198850304318
   PubMed Web of Science ®Google Scholar
• NilssonPMollerLSolkadKAdverse effects of psychosocial stress on gonadal function and insulin levels in middle aged malesJ Intern Med19952374794867738488
   PubMed Web of Science ®Google Scholar
• SchiaviRCRehmanJSexuality and agingUrol Clin North Am1995227117267483124
   PubMed Web of Science ®Google Scholar
• GrayPBSinghABWoodhouseLJDose-dependent effects of testosterone on sexual function, mood, and visuospatial cognition in older menJ Clin Endocrinol Metab2005903838384615827094
   PubMed Web of Science ®Google Scholar
• MoralesABuvatJGoorenLJEndocrine aspects of sexual dysfunction in menJ Sex Med20041698116422986
   PubMed Web of Science ®Google Scholar
• YassinAASaadFDramatic improvement of penile venous leakage upon testosterone administration. A case report and review of literatureAndrologia200638343716420241
   PubMed Web of Science ®Google Scholar
• LivermanCTBlazerDGTestosterone and aging: clinical research directionsWashington, DCInstitute of Medicine. The National Academies Press2004
   Google Scholar
• KrauseWMuellerUMazurATestosterone supplementation in the aging male: which questions have been answered?Aging Male20058313816106921
   PubMedGoogle Scholar
• HajjarRRKaiserFEMorleyJEOutcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysisJ Clin Endocrinol Metab19978237939360543
   PubMed Web of Science ®Google Scholar
• ShabsighRThe effects of testosterone on the cavernous tissue and erectile functionWorld J Urol19971521269066090
   PubMed Web of Science ®Google Scholar
• MorleyJEPerryHMKaiserFEEffect of testosterone replacement therapy in old hypogonadal males: a preliminary studyJ Am Geriatr Soc1993411491528426037
   PubMed Web of Science ®Google Scholar
• CavalliniGCaraccioloSVitaliGModeniniFBiagiottiGCarnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male agingUrology20046364164615072869
   PubMed Web of Science ®Google Scholar
• SnyderPJPeacheyHHannoushPBerlinJALohLLenrowDAEffect of testosterone treatment on body composition and muscle strength in men over 65 years of ageJ Clin Endocrinol Metab1999842647265310443654
   PubMed Web of Science ®Google Scholar
• MeikleAWArverSDobsASSandersSWMazerNAAndroderm: A permeation-enhanced, non-scrotal testosterone transdermal system for the treatment of male hypogonadismBhasinPharmacology, biology, and clinical applications of androgensNew York, NYWiley Liss, Inc1996449457
   Google Scholar
• CoronaGPetroneLFisherADMansaniRBandiniESix-month administration of 1% testosterone gel is able to restore erectile function in hypogonadal patients with erectile dysfunctionArch Ital Urol Androl200880310310819009866
   PubMedGoogle Scholar
• BlackAMDayAGMoralesAThe reliability of clinical and biochemical assessment in symptomatic late-onset hypogonadism: Can a case be made for a 3-month therapeutic trial?BJU Int2004941066107015541129
   PubMed Web of Science ®Google Scholar
• ShabsighRKaufmanJMSteidleCPadma-NathanHRandomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil aloneJ Urol200417265866315247755
   PubMed Web of Science ®Google Scholar
• GreensteinAMabjeeshNJSoferMKaverIMatzkinHChenJDoes sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed?J Urol200517353053215643239
   PubMed Web of Science ®Google Scholar
• BehreHMTestosterone and erectionNieschlagEBehreHMTestosterone: action, deficiency, substitutionCambridgeCambridge University Press2004333346
   Google Scholar
• KalintchenkoSYKozlovGIGontcharovNPOral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy aloneAging Male20036949912898793
   PubMedGoogle Scholar
• GrecoEASperaGAversaACombining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidencesEur Urol20065094094716979814
   PubMed Web of Science ®Google Scholar
• AversaAIsidoriAMGrecoEAGiannettaEGianfrilliDSperaEHormonal supplementation and erectile dysfunctionEur Urol20044553553815082192
   PubMed Web of Science ®Google Scholar
• MinerMCantyDJShabsighRTestosterone replacement therapyPostgrad Med2008120313015318824832
   PubMed Web of Science ®Google Scholar
• KarazindiyanoğluSCayanSThe effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadismAging Male200811314614918821291
   PubMed Web of Science ®Google Scholar
• FairfieldWPFinkelsteinJSKlibanskiAGrinspoonSKOsteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndromeJ Clin Endocrinol Metab2001862020202611344201
   PubMed Web of Science ®Google Scholar
• MeierCNguyenTVHandelsmanDJEndogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology StudyArch Intern Med2008168475418195195
   PubMed Web of Science ®Google Scholar
• KennyAMPrestwoodKMMarcelloKMRaiszLGDeterminants of bone density in healthy older men with low testosterone levelsJ Gerontol A Biol Sci Med Sci200055M492M49710995046
   PubMed Web of Science ®Google Scholar
• FinkHAEwingSKEnsrudKEAssociation of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older menJ Clin Endocrinol Metab2006911039083901516849417
   PubMed Web of Science ®Google Scholar
• CompstonJESex steroids and bonePhysiol Rev200181141944711152762
   PubMed Web of Science ®Google Scholar
• AmoryJKWattsNBEasleyKAExogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosteroneJ Clin Endocrinol Metab20048950351014764753
   PubMed Web of Science ®Google Scholar
• SvartbergJAgledahlIFigenschauYSildnesTWaterlooKJordeRTestosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hipInt J Impot Res200820437838718480825
   PubMed Web of Science ®Google Scholar
• BehreHHKlieschSLeifkeELinkTMNieschlagELong term effect of testosterone therapy on bone mineral density in hypogonadal menJ Clin Endocrinol Metab199782238623909253305
   PubMed Web of Science ®Google Scholar
• SaggeseGBertelloniSBaroncelliGISex steroids and acquisition of bone massHorm Res19974865729434047
   PubMedGoogle Scholar
• CenterJRNguyenTVSambrookPNEismanJAHormonal and biochemical parameters in the determination of osteoporosis in elderly menJ Clin Endocrinol Metab1999843626363510523006
   PubMed Web of Science ®Google Scholar
• HolzbeierleinJMCastleEThrasherJBComplications of androgen deprivation therapy: prevention and treatmentOncology (Williston Park)200418330330915065701
   PubMed Web of Science ®Google Scholar
• Van den BeldAWde JongFHGrobbeeDEPolsHALambertsSWMeasures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly menJ Clin Endocrinol Metab20008593276328210999822
   PubMed Web of Science ®Google Scholar
• MichaelHHärkönenPLVäänänenHKHentunenTAEstrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorptionJ Bone Miner Res200520122224223216294275
   PubMed Web of Science ®Google Scholar
• TenoverJSEffects of testosterone supplementation in the aging maleJ Clin Endocrinol Metab199275109210981400877
   PubMed Web of Science ®Google Scholar
• FreitasSSBarrett-ConnorEEnsrudKERate and circumstances of clinical vertebral fractures in older menOsteoporos Int20081961562318038109
   PubMed Web of Science ®Google Scholar
• SchousboeJTTaylorBCFinkHACost-effectiveness of bone densitometry followed by treatment of osteoporosis in older menJAMA200729862963717684185
   PubMed Web of Science ®Google Scholar
• KennyAMPrestwoodKMGrumanCAMarcelloKMRaiszLGEffects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levelsJ Gerontol A Biol Sci Med Sci200156266272
   PubMed Web of Science ®Google Scholar
• De RosaMPaesanoLNuzzoVBone mineral density and bone markers in hypogonadotropic and hypergonadotropic hypogonadal men after prolonged testosterone treatmentJ Endocrinol Invest200124424625211383911
   PubMed Web of Science ®Google Scholar
• BehreHMKlieschSLeifkeELinkTMNieschlagELong-term effect of testosterone therapy on bone mineral density in hypogonadal menJ Clin Endocrinol Metab19978223869253305
   PubMed Web of Science ®Google Scholar
• LeifkeEKornerHCLinkTMBehreHMPetersPENieschlagEEffects of testosterone replacement on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal menEur J Endocrinol1991385158
   Google Scholar
• MichalJTraczSiderasKBolonERAClinical review: testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trialsJ Clin Endocrinol Metab9162011201616720668
   PubMed Web of Science ®Google Scholar
• AndersonFHFrancisRMFaulknerKAndrogen supplementation in eugonadal men with osteoporosis. Effects of 6 months of treatment on bone mineral density and cardiovascular risk factorsBone1996181711788833211
   PubMed Web of Science ®Google Scholar
• AmoryJKWattsNBEasleyKAExogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosteroneJ Clin Endocrniol Metab200489503510
   PubMed Web of Science ®Google Scholar
• BhasinSregulation of body composition by androgensJ Endocrinol Invest200326981482214964432
   PubMed Web of Science ®Google Scholar
• FronteraWRHughesVVFiataroneMAFieldingRAAging and skeletal muscle: a 12 year longitudinal studyJ Appl Physiol2000881321132610749826
   PubMed Web of Science ®Google Scholar
• ReedRLPearlmutterLJochumKMeredithKEMooradianADThe relationship between muscle mass and muscle strength in the elderlyJ Am Geriatr Soc1991395555911805811
   PubMed Web of Science ®Google Scholar
• MaurasNHayesVWelchSTestosterone deficiency in young men; marked alterations in whole body protein kinetics, strength, and adiposityJ Clin Endocrinol Metab199838618861892
   Google Scholar
• BaumgartnerRNWatersDLGallagherDMorleyJEGarryPJPredictors of skeletal muscle mass in elderly men and womenMech Ageing Dev199910712313610220041
   PubMed Web of Science ®Google Scholar
• VerhaarHJJSamsonMMAlemanAde VriesWRde VreedePLKoppeschaarHPFThe relationship between indices of muscle function and circulating anabolic hormones in healthyAging Male200037580
   Google Scholar
• MudaliSDobsASEffects of testosterone on body composition of the aging maleMech Ageing Dev2004125429730415063106
   PubMed Web of Science ®Google Scholar
• FerrandoAASheffield-MooreMPaddon-JonesDWolfeRRUrbanRJDifferential anabolic effects of testosterone and amino acid feeding in older menJ Clin Endocrinol Metab20038835836212519877
   PubMed Web of Science ®Google Scholar
• PageSTAmoryJKBowmanFDExogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum TJ Clin Endocrinol Metab2005901502151015572415
   PubMed Web of Science ®Google Scholar
• HarmanSMBlackmanMRThe effects of growth hormone and sex steroid on lean body mass, fat mass, muscle strength, cardiovascular endurance and adverse events in healthy elderly women and menHorm Res200360121124
   PubMedGoogle Scholar
• TenoverJSAndrogen administration in aging menEndocrinol Metab Clin199423877889
   Web of Science ®Google Scholar
• UrbanRJBodenburgCGilkisonCTestosterone administration to elderly men increases skeletal muscle strength and protein synthesisAm J Physiol1995269E820E8267491931
   PubMed Web of Science ®Google Scholar
• SihRMorleyJEKaiserFEPerryHMIIIPatrickPRossCTestosterone replacement in older hypogonadal men: a 12 months randomized controlled studyJ Clin Endocrinol Metab199782166116679177359
   PubMed Web of Science ®Google Scholar
• MorleyJEPerryHM3rdKaiserFEEffects of testosterone replacement therapy in old hypogonadal males: a preliminary studyJ Am Geriatr Soc1993411491528426037
   PubMed Web of Science ®Google Scholar
• PerryHMMillerDKPatrickPTestosterone and leptin in older African-American men: relationship to age, strength, function, and seasonMetabolism2000491085109110954031
   PubMed Web of Science ®Google Scholar
• BreuerBTrungoldSMartucciCRelationship of sex hormone levels to dependence of daily living in the frail elderlyMaturitas20013914715911514113
   PubMed Web of Science ®Google Scholar
• BhasinSTestosterone supplementation for aging-associated sarcopeniaJ Gerontol A Biol Sci Med Sci200358111002100814630881
   PubMed Web of Science ®Google Scholar
• SteidleCSchwartzSJacobyKAA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual functionJ Clin Endocrinol Metab2003882673268112788872
   PubMed Web of Science ®Google Scholar
• WangCCunninghamGDobsALong-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal menJ Clin Endocrinol Metab2004892085209815126525
   PubMed Web of Science ®Google Scholar
• Barrett-ConnorEVon MuhlenDGKritz-SilversteinDBioavailable testosterone and depressed mood in older men: the Rancho Bernardo StudyJ Clin Endocrinol Metab19998457357710022418
   PubMed Web of Science ®Google Scholar
• SchmidtPJBerlinKLDanaceauMAThe effects of pharmacologically induced hypogonadism on mood in healthy menArch Gen Psychiatry200461997100415466673
   PubMed Web of Science ®Google Scholar
• BoothAJohnsonDRGrangerDATestosterone and men’s depression: the role of social behaviorJ Health Soc Behav19994013014010467760
   PubMed Web of Science ®Google Scholar
• KratzikCWSchatzlGLacknerJEMood changes, body mass index and bioavailable testosterone in healthy men: results of the Androx Vienna Municipality StudyBJU Int200710061461817550413
   PubMed Web of Science ®Google Scholar
• SeidmanSNSpatzERizzoCRooseSPTestosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trialJ Clin Psychiatry200162640641211465516
   PubMed Web of Science ®Google Scholar
• EnglishKMSteedsRPJonesTHDiverMJChannerKSLow-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled studyCirculation20001021906191111034937
   PubMed Web of Science ®Google Scholar
• ReddyPWhiteCMDunnABMoynaNMThompsonPDThe effect of testosterone on health-related quality of life in elderly males: a pilot studyJ Clin Pharm Ther20002542142611123495
   PubMed Web of Science ®Google Scholar
• TrickerRCasaburiRStorerTWThe effects of supraphysiological doses of testosterone on angry behavior in healthy eugonadal men: a clinical research center studyJ Clin Endocrinol Metab199681375437588855834
   PubMed Web of Science ®Google Scholar
• HarenMTWittertGAChapmanIMEffect of oral testosterone undecanoate on visuospatial cognition, mood and quality of life in elderly men with low–normal gonadal statusMaturitas20055012413315653010
   PubMed Web of Science ®Google Scholar
• PopeHGJKouriEMHudsonJIEffects of supraphysiologic doses of testosterone on mood and aggression in normal men. A randomized controlled trialArch Gen Psychiatry20005713314010665615
   PubMed Web of Science ®Google Scholar
• SuTPPagliaroMSchmidtPJNeuropsychiatric effects of anabolic steroids in male normal volunteersJAMA1993269276027648492402
   PubMed Web of Science ®Google Scholar
• WangCWAlexanderGBermanNTestosterone replacement therapy improves mood in hypogonadal menóa clinical research center studyJ Clin Endocrinol Metab19968135788855804
   PubMed Web of Science ®Google Scholar
• LunenfeldBNieschlagETestosterone therapy in the aging maleAging Male20071013915317701658
   PubMed Web of Science ®Google Scholar
• MorleyJETestosterone replacement in older men and womenJ Gend Specif Med20014495311480098
   PubMedGoogle Scholar
• GruenewaldDAMatsumotoAMTestosterone supplementation therapy for older men: potential benefits and risksJ Am Geriatr Soc20035110111512534854
   PubMed Web of Science ®Google Scholar
• EhrenreichHHalarisARuetherEPsychoendocrine sequelae of chronic testosterone deficiencyJ Psychiatr Res199933b379387
   Web of Science ®Google Scholar
• HeuserIHartmannAOertelHAndrogen replacement in a 48, XXYY-male patientArch Gen Psychiatry19995619419510025446
   PubMed Web of Science ®Google Scholar
• SeidmanSNRabkinJGTestosterone replacement therapy for hypogonadal men with SSRI-refractory depressionJ Affect Disord1998482–31571619543205
   PubMed Web of Science ®Google Scholar
• OrengoCAFullertonLKunikMESafety and efficacy of testosterone gel 1% augmentation in depressed men with partial response to antidepressant therapyJ Geriatr Psychiatry Neurol200518202415681624
   PubMed Web of Science ®Google Scholar
• RabkinJGWagnerGJRabkinRTestosterone therapy for HIV+ men with and without clinical hypogonadismJ Clin Psychopharmacol19991919279934939
   PubMed Web of Science ®Google Scholar
• GrinspoonSCorcoranCStanleyTEffects of hypogonadism and testosterone administration on depression indices in HIV-infected menJ Clin Endocrinol Metab200085606510634364
   PubMed Web of Science ®Google Scholar
• SeidmanSNMiyazakiMRooseSPIntramuscular testosterone supplementation to selective serotonin reuptake inhibitor in treatment-resistant depressed men: randomized placebo-controlled clinical trialJ Clin Psychopharmacol20052558458816282843
   PubMed Web of Science ®Google Scholar
• PerryPJYatesWRWilliamsRDTestosterone therapy in late-life major depression in malesJ Clin Psychiatry2002631096110112523867
   PubMed Web of Science ®Google Scholar
• SeidmanSNAraujoABRooseSPMcKinlayJBTestosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged menBiol Psychiatry20015037137611543741
   PubMed Web of Science ®Google Scholar
• HarkonenKHuhtaniemiIMakinenJThe polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing menInt J Androl20032618719412755998
   PubMedGoogle Scholar
• AmiazRASeidmanSNStuartNBTestosterone and depression in menCurr Opin Endocrinol Diabetes Obes200815327828318438177
   PubMedGoogle Scholar
• ShamlianNTColeMGAndrogen treatment of depressive symptoms in older men: a systematic review of feasibility and effectivenessCan J Psychiatry20065129529916986819
   PubMed Web of Science ®Google Scholar
• KanayamaGAmiazRSeidmanSNPopeHGJTestosterone supplementation for depressed men: current research and suggested treatment guidelinesExp Clin Psychopharmacol20071552953818179305
   PubMed Web of Science ®Google Scholar
• GillettMJMartinsRNClarnetteRMChubbSABruceDGYeapBBRelationship between testosterone, sex hormone binding globulin and plasma amyloid beta peptide 40 in older men with subjective memory loss or dementiaJ Alzheimers Dis2003526726914624021
   PubMed Web of Science ®Google Scholar
• MorleyJEKaiserFRaumWJPotentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormoneProc Natl Acad Sci U S A199794753775429207127
   PubMed Web of Science ®Google Scholar
• MoffatSDZondermanABMetterEJKawasCBlackmanMRHarmanSMFree testosterone and risk for Alzheimer disease in older menNeurology20046218819314745052
   PubMed Web of Science ®Google Scholar
• HogervorstEBandelowSCombrinckMSmithADLow free testosterone is an independent risk factor for Alzheimer’s diseaseExp Gerontol2004391633163915582279
   PubMed Web of Science ®Google Scholar
• McKeeverWFDeyoATestosterone, dihydrotestosterone and spatial task performance of malesBull Psychonomic Soc199028305308
   Google Scholar
• Barrett-ConnorEGoodman-GruenDPatayBEndogenous sex hormones and cognitive function in older menJ Clin Endocrinol Metab1999843681368510523014
   PubMed Web of Science ®Google Scholar
• YaffeKLuiL-YZmudaJCauleyJSex hormones and cognitive function in older menJ Am Geriatr Soc20025070771211982672
   PubMed Web of Science ®Google Scholar
• ThilersPPMacDonaldSWSHerlitzAThe association between endogenous free testosterone and cognitive performance: a population-based study in 35–90 year-old men and womenPsychoneuroendocrinology20063156557616487665
   PubMed Web of Science ®Google Scholar
• YeapBBAlmeidaOPHydeZChubbSAPHankeyGJJamrozikKHigher serum free testosterone is associated with better cognitive function in older men, whilst total testosterone is not. The Health In Men StudyClin Endocrinol200868404412
   PubMed Web of Science ®Google Scholar
• FondaSJBertrandRO’DonnellALongcopeCMcKinlayJBAge, hormones, and cognitive functioning among middle aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging StudyJ Gerontol A Biol Sci Med Sci20056038539015860479
   PubMed Web of Science ®Google Scholar
• YonkerJEErikssonENilssonL-GHerlitzANegative association of testosterone on spatial visualisation in 35 to 80 year old menCortex20064237638616771043
   PubMed Web of Science ®Google Scholar
• MartinDMWittertGBurnsNRHarenMTSugarmanRTestosterone and cognitive function in ageing men: data from the Florey Adelaide Male Ageing Study (FAMAS)Maturitas20075718219417287097
   PubMed Web of Science ®Google Scholar
• BurkhardtMSFosterJKClarnetteRMChubbSAPBruceDGDrummondPDInteraction between testosterone and apolipoprotein E e4 status on cognition in healthy older menJ Clin Endocrinol Metab2006911168117216368754
   PubMed Web of Science ®Google Scholar
• ChuLWTamSLeePWBioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older menClin Endocrinol (Oxf)200868458959817973937
   PubMed Web of Science ®Google Scholar
• CherrierMMRoseALHiganoCThe effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancerJ Urol20031701808181114532781
   PubMed Web of Science ®Google Scholar
• SalminenEKPortinRIKoskinenAHeleniusHNurmiMAssociations between serum testosterone fall and cognitive function in prostate cancer patientsClin Cancer Res2004107575758215569988
   PubMed Web of Science ®Google Scholar
• AlmeidaOPWaterreusASpryNFlickerLMartinsRNOne year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in menPsychoneuroendocrinology20042981071108115219659
   PubMed Web of Science ®Google Scholar
• HogervorstEWilliamsJBudgeMBarnetsonLCombrinckMSmithADSerum total testosterone is lower in men with Alzheimer’s diseaseNeuro Endocrinol Lett200122316316811449190
   PubMed Web of Science ®Google Scholar
• BowenRLIsleyJPAtkinsonRLAn association of elevated serum gonadotropin concentrations and Alzheimer disease?J Neuroendocrinol200012435135410718932
   PubMed Web of Science ®Google Scholar
• GibbsRBGaborREstrogen and cognition: applying preclinical findings to clinical perspectivesJ Neurosci Res200374563764314635215
   PubMed Web of Science ®Google Scholar
• BeauchetOTestosterone and cognitive function: current clinical evidence of a relationshipEur J Endocrinol200615577378117132744
   PubMed Web of Science ®Google Scholar
• OrwollESOviattSKBiddleJTransdermal testosterone supplementation in normal older menProc 74th Meeting of The Endocrine SocSan Antonio, TX1992319
   Google Scholar
• AlexanderGMSwerdloffRSWangCAndrogen-behavior correlations in hypogonadal men and eugonadal menHorm Behav19983385949647934
   PubMed Web of Science ®Google Scholar
• JanowskiSCOviattSKOrwollESTestosterone influences spatial cognition in older menBehav Neurosci19941083253328037876
   PubMed Web of Science ®Google Scholar
• JanowskyJSChavezBJOrwollESex steroids modify working memoryCogn Neurosci200012407414
   PubMed Web of Science ®Google Scholar
• CherrierMMCraftSMatsumotoAHCognitive changes associated with supplementation of testosterone or dihydrotestosterone in mildly hypogonadal men: a preliminary reportJ Androl20032456857612826696
   PubMed Web of Science ®Google Scholar
• CherrierMMMatsumotoAMAmoryJKAsthanaSBremnerWPeskindERTestosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairmentNeurology2005642063206815985573
   PubMed Web of Science ®Google Scholar
• LuPHMastermanDAMulnardRCotmanCMillerBYaffeKEffects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly menArch Neurol20066317718516344336
   PubMed Web of Science ®Google Scholar
• MakiPMErnstMLondonEDMordecaiKLPerschlerPDursoSCIntramuscular testosterone treatment in elderly men: evidence of memory decline and altered brain functionJ Clin Endocrinol Metab2007924107411417726086
   PubMed Web of Science ®Google Scholar
• TanRSCulbersonJWAn integrative review on current evidence of testosterone replacement therapyfor the andropauseMaturitas200345152712753940
   PubMed Web of Science ®Google Scholar
• KennyAMFabregasGSongCBiskupBBellantonioSEffects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive lossJ Gerontol A Biol Sci Med Sci200459757814718489
   PubMed Web of Science ®Google Scholar
• van den BeldAWBotsMLJanssenJAPolsHALambertsSWGrobbeeDEEndogenous hormones and carotid atherosclerosis in elderly menAm J Epidemiol2003157253112505887
   PubMed Web of Science ®Google Scholar
• MakinenJJarvisaloMJPollanenPPerheentupaAIrjalaKKoskenvuoMIncreased carotid atherosclerosis in andropausal middle-aged menJ Am Coll Cardiol2005451603160815893174
   PubMed Web of Science ®Google Scholar
• MullerMvan den BeldAWBotsMLGrobbeeDELambertsSWvander SchouwYTEndogenous sex hormones and progression of carotid atherosclerosis in elderly menCirculation20041092074207915096452
   PubMed Web of Science ®Google Scholar
• TivestenAMellstromDJutbergerHFagerbergBLernfeltBOrwollELow serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in SwedenJ Am Coll Cardiol2007501070107617825717
   PubMed Web of Science ®Google Scholar
• HakAEWittemanJCMde JongFHGeerlingsMIHofmanAPolsHAPLow levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam studyJ Clin Endocrinol Metab2002873632363912161487
   PubMed Web of Science ®Google Scholar
• KapoorDClarkeSChannerKSJonesTHErectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetesInt J Androl20073050050718028199
   PubMed Web of Science ®Google Scholar
• MaRC-WSoW-YYangXYuLW-LKongAP-SKoGT-CErectile dysfunction predicts coronary heart disease in type 2 diabetesJ Am Coll Cardiol2008512045205018498959
   PubMed Web of Science ®Google Scholar
• VermeulenAKaufmanJMGiagulliVAInfluence of some biological indices on the sex hormone binding globulin and androgens in aging and obese menJ Clin Endocrinol Metab199681182118278626841
   PubMed Web of Science ®Google Scholar
• ZumoffBStrainGWMillerLKPlasma free and non sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesityJ Clin Endocrinol Metab1990719299312401718
   PubMed Web of Science ®Google Scholar
• PasqualiRCasimirriFCantobelliSEffect of obesity and body fat distribution on sex hormones and insulin in menMetabolism1991401011041984562
   PubMed Web of Science ®Google Scholar
• KalyaniRRDobsASAndrogen deficiency, diabetes, and the metabolic syndrome in menCurr Opin Endocrinol Diabetes Obes20071422623417940444
   PubMedGoogle Scholar
• SelvinEFeinleibMZhangLAndrogens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III)Diabetes Care20073023423817259487
   PubMed Web of Science ®Google Scholar
• HaffnerSMValdezRASternMPObesity, body fat distribution and sex hormones in menInt J Obes199317634639
   Web of Science ®Google Scholar
• PhillipsGBRelationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarctionMetabolism20035278479012800107
   PubMed Web of Science ®Google Scholar
• CohenPGThe hypogonadal-obesity cycleMed Hypotheses199952495110342671
   PubMed Web of Science ®Google Scholar
• JonesTHTestosterone associations with erectile dysfunction, diabetes and the metabolic syndromeEur Urol (Suppl)20076847857
   Web of Science ®Google Scholar
• ErFMichelsGGassanovNRiveroFHoppeUCTestosterone induces cytoprotection by activating ATPsensitive Kþ channels in the cardiac mitochondrial inner membraneCirculation20041103100310715520315
   PubMed Web of Science ®Google Scholar
• NettleshipJEJonesTHChannerKSJonesRDPhysiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouseCirculation20071162427243417984376
   PubMed Web of Science ®Google Scholar
• KalmeTSeppalaMQiaoQSex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly menJ Clin Endocrinol Metab2005901550155615613437
   PubMed Web of Science ®Google Scholar
• KupelianVPageSTAraujoABLow sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese menJ Clin Endocrinol Metab20069184385016394089
   PubMed Web of Science ®Google Scholar
• DerbyCAZilberSBrambillaDMoralesKHMcKinlayJBBody mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the Massachusetts Male Ageing StudyClin Endocrinol (Oxf)20066512513116817831
   PubMed Web of Science ®Google Scholar
• RodriguezAMullerDCMetterEJAging, androgens, and the metabolic syndrome in a longitudinal study of agingJ Clin Endocrinol Metab2007923568357217595254
   PubMed Web of Science ®Google Scholar
• SimonDPreziosiPBarrett-ConnorEInterrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom StudyDiabetologia1992351731771547923
   PubMed Web of Science ®Google Scholar
• Barrett-ConnorEKhawKTEndogenous sex hormones and cardiovascular disease in men: a prospective population-based studyCirculation1988785395453409497
   PubMed Web of Science ®Google Scholar
• PitteloudNMoothaVKDwyerAARelationship between testosterone levels, insulin sensitivity, and mitochondrial function in menDiabetes Care2005281636164215983313
   PubMed Web of Science ®Google Scholar
• MünzerTHarmanSMChristmasCEffects of administration of testosterone and/or GH in healthy aged men [abstract]Presented at 2nd World Congress on the Aging MaleGeneva, Switzeland2000Aging Male200033
   Google Scholar
• AbateNHaffnerSMGargASex steroid hormones, upper body obesity and insulin resistanceJ Clin Endocrinol Metab2002874522452712364429
   PubMed Web of Science ®Google Scholar
• KapoorDGoodwinEChannerKSJonesTHTestosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetesEur J Endocrinol200615489990616728551
   PubMed Web of Science ®Google Scholar
• CorralesJJBurgoRMGarca-BerrocalBPartial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic controlMetabolism20045366667215131775
   PubMed Web of Science ®Google Scholar
• BasuRDallaMCCampioniMEffect of 2 years of testosterone replacement on insulin secretion, insulin action, glucose effectiveness, hepatic insulin clearance, and postprandial glucose turnover in elderly menDiabetes Care2007301972197817496236
   PubMed Web of Science ®Google Scholar
• TenoverJLEffects of androgen supplementation in aging malesOddensBVermeulenAAndrogens and the aging maleNew York, LondonParthenon Publishing Group1996191204
   Google Scholar
• HaffnerJMAndrogens in relation to cardiovascular disease and insulin resistance in aging menOddensBVermeulenAAndrogens and the aging maleNew York, LondonParthenon Publishing Group19966584
   Google Scholar
• MoorjaniSDupontALabrieFIncrease in plasma high density lipoprotein concentration following complete androgen blockade in men with prostatic carcinomaMetabolism1987362442503102895
   PubMed Web of Science ®Google Scholar
• WhitselEABoykoEJMatsumotoAMAnawaltBDSiscovickDSIntramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysisAm J Med200111126126911566455
   PubMed Web of Science ®Google Scholar
• Emmelot-VonkMHVerhaarHJNakhai PourHREffect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trialJAMA20082996634
   Web of Science ®Google Scholar
• DobsASMeikleAWArverSSandersSWCaramelliKEMazerNAPharmacokinetics, efficacy, and safety of a permeation enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal menJ Clin Endocrinol Metab1999843469347810522982
   PubMed Web of Science ®Google Scholar
• MarinPHolmängSGustafsonCAndrogen treatment of abdominally obese menObesity Res19931245248
   PubMedGoogle Scholar
• MarinPLonnBAnderssonBOdenBOlbeLBengtssonBAAssimilation of triglycerides in subcutaneous and intra-abdominal adipose tissues in vivo in menJ Clin Endocrinol Metab199681101810228772568
   PubMed Web of Science ®Google Scholar
• XuXDe PergolaGBjorntorpPTestosterone increases lipolysis and the number ß-adrenoreceptors in male rat adipocytesEndocrinology19911283793811846106
   PubMed Web of Science ®Google Scholar
• MarinPOdenBBjörntorpPAssimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgensJ Clin Endocrinol Metab1995802392437829619
   PubMed Web of Science ®Google Scholar
• ZmudaJMFahrenbachMCYounkinBTThe effect of testosterone aromatization on high-density lipoprotein cholesterol level and postheparin lipolytic activityMetabolism1993424464508487666
   PubMed Web of Science ®Google Scholar
• JacobsDRJrMebaneILBangdiwalaSICriquiMHTyrolerHAHigh density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence StudyAm J Epidemiol199013132472293751
   PubMed Web of Science ®Google Scholar
• SinghABHsiaSAlaupovicPThe effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young menJ Clin Endocrinol Metab20028713614311788637
   PubMed Web of Science ®Google Scholar
• PhillipsGPinkernellBHJingTYThe association between hypotestosteronemia and coronary heart disease in menArterioscler Thromb1994147017068172848
   PubMed Web of Science ®Google Scholar
• VermeulenAGoemaereSKaufmanJMSex hormones, body composition and agingAging Male19992815
   Google Scholar
• SeidellJCBjörntorpPSjöströmLKvistHSannerstedtRVisceral fat accumulation in men is positively associated with insulin, glucose and C-peptide levels, but negatively with testosterone levelsMetabolism1990398979012202881
   PubMed Web of Science ®Google Scholar
• TchernofALabrieFBelangerARelationships between endogenous sex steroid hormones, sex hormone binding globulin and lipoprotein levels in men: contribution of visceral obesity, insulin levels and other metabolic variablesAtherosclerosis19971332352449298684
   PubMed Web of Science ®Google Scholar
• KannellWBCupplesLARamaswamiRStokesJJrKregerBEHiggingsMRegional obesity and the risk of coronary disease: The Framingham StudyJ Clin Epidemiol1991441831901995775
   PubMed Web of Science ®Google Scholar
• BjörntorpPVisceral obesity: a civilisation syndromeObes Res1993120622216350574
   PubMedGoogle Scholar
• KabakciGYildirirACanIUnsalIErbasBRelationship between endogenous sex hormone levels, lipoproteins and coronary atherosclerosis in men undergoing coronary angiographyCardiology19999222122510844380
   PubMed Web of Science ®Google Scholar
• HaddadRMKennedyCCCaplesSMTestosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trialsMayo Clin Proc2007821111317285780
   PubMed Web of Science ®Google Scholar
• AllanCAMcLachlanRIAge-related changes in testosterone and the role of replacement therapy in older menClin Endocrinol200460653670
   PubMed Web of Science ®Google Scholar
• HaffnerJEMossSEKleinBEKKleinRSex hormones and DHEASO4 in relation to ischemic heart disease in diabetic subjects. The WESDR StudyDiabetes Care199619104510508886548
   PubMed Web of Science ®Google Scholar
• Barrett-ConnorEKhawKSEndogenous sex hormone levels and cardiovascular disease in men: a prospective population based studyCirculation1988788539543
   Web of Science ®Google Scholar
• CauleyJAGutaiJPKullerLHDaiWSUsefulness of sex steroid hormone levels in predicting coronary artery disease in menAm J Cardiol1987607717773661391
   PubMed Web of Science ®Google Scholar
• GoldbergRBRabinANAlexanderANDoelleGCGetzGSSuppression of plasma testosterone leads to an increase in serum total and high density lipoprotein cholesterol and Apo A and BJ Clin Endocrinol Metab1985602032073917267
   PubMed Web of Science ®Google Scholar
• CaronPBennetACamareLLouvetJPBoneuSSiePPlasminogen activator inhibitor in plasma is related to testosterone in manMetabolism198938101010132507874
   PubMed Web of Science ®Google Scholar
• PoldermanKHStehouwerCDAvan de KampGJDekkerGHVerheugtFWAGoorenLJGInfluence of sex hormones on plasma endothelin levelsAnn Intern Med19931184294318439117
   PubMed Web of Science ®Google Scholar
• AjayiAATestosterone increases platelet thromboxane A2 receptor densityCirculation19959127402747
   Web of Science ®Google Scholar
• SpivakJLThe blood in systemic disordersLancet20003551707171210905258
   PubMed Web of Science ®Google Scholar
• ZitzmannMNieschlagEAndrogens and erythropoiesisNieschlagEBehreHMTestosterone: action, deficiency, substitutionCambridgeCambridge University Press2004283296
   Google Scholar
• MarksLSMazerNAMostaghelEEffect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trialJAMA2006296192369237117105801
   PubMed Web of Science ®Google Scholar
• HolyoakJDCrawfordEDMeachamRBtestosterone and the testosterone: implications for the treatment of hypogonadal menCurr Urol Rep2008950050518947516
   PubMedGoogle Scholar
• RoddamAWAllenNEApplebyPKeyTJEndogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studiesJ Natl Cancer Inst20081001708318230794
   PubMed Web of Science ®Google Scholar
• CarpenterWRRobinsonWRGodleyPAGetting over testosterone: postulating a fresh start for etiologic studies of prostate cancerJ Natl Cancer Inst200810015815918230791
   PubMed Web of Science ®Google Scholar
• HolmängSMarinPLindstedtGHedelinHEffect of long-term oral testosterone-undecanoate treatment on prostatic volume and serum prostate specific antigen in eugonadal middle-aged menProstate199323991067690956
   PubMed Web of Science ®Google Scholar
• KriegMNassRTunnSEffect of aging on endogenous level of 5a-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostateJ Clin Endocrinol Metab1993773753817688377
   PubMed Web of Science ®Google Scholar
• SlaterSOliverRTDTestosterone: its role in development of prostate cancer and potential risk from use as hormone replacement therapyDrugs Aging20001743143911200304
   PubMed Web of Science ®Google Scholar
• PecherskyAVMazurovVISemiglazovVFKarpischenkoAIMikhailichenkoVVUdintsevAVAndrogen administration in middle-aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volumeInt J Androl20022511912511903662
   PubMedGoogle Scholar
• CurranMJBihrleWIIIDramatic rise in prostate-specific antigen after androgen replacement in a hypogonadal man with occult adenocarcinoma of the prostateUrology1999534234249933071
   PubMed Web of Science ®Google Scholar
• LoughlinKRRichieJPProstate cancer after exogenous testosterone treatment for impotenceJ Urol199715718459112543
   PubMed Web of Science ®Google Scholar
• RhodenELMorgentalerATestosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasiaJ Urol20031706 pt 12348235114634413
   PubMed Web of Science ®Google Scholar
• SnyderPJPeacheyHBerlinJAEffects of testosterone replacement in hypogonadal menJ Clin Endocrinol Metab2000852670267710946864
   PubMed Web of Science ®Google Scholar
• CarterHBPearsonJDMetterEJLongitudinal evaluation of serum androgen levels in men with and without prostate cancerProstate19952725317541528
   PubMed Web of Science ®Google Scholar
• HeikkilaRAhoKHeliovaaraMSerum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal studyCancer19998631231510421267
   PubMed Web of Science ®Google Scholar
• AgarwalPKOefeleinMGTestosterone replacement therapy after primary treatment for prostate cancerJ Urol200517353353615643240
   PubMed Web of Science ®Google Scholar
• FerreiraULeitaoVADenardiFMatheusWEStopigliaRMNettoNRJrIntermittent androgen replacement for intense hypogonadism symptoms in castrated patientsProstate Cancer Prostatic Dis20069394116276352
   PubMed Web of Science ®Google Scholar
• WeissJMHuangWYRinaldiSEndogenous sex hormones and the risk of prostate cancer: a prospective studyInt J Cancer2008122102345235018172860
   PubMed Web of Science ®Google Scholar
• FowlerJEJrWhitmoreWFJrConsiderations for the use of testosterone with systemic chemotherapy in prostatic cancerCancer198249137313777059952
   PubMed Web of Science ®Google Scholar
• McConnellJDProstatic growth: new insights into hormonal regulationBr J Urol199576Suppl 15107544215
   PubMedGoogle Scholar
• SarosdyMFTestosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapyCancer200710953654117183557
   PubMed Web of Science ®Google Scholar
• KheraMLipshultzLIThe role of testosterone replacement therapy following radical prostatectomyUrol Clin North Am20073454955317983894
   PubMed Web of Science ®Google Scholar
• SwerdloffRSWangCThree-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gelAging Male2003620721114628501
   PubMedGoogle Scholar
• El-SakkaAIHassobaHMElbakryAMHassanHAProstatic specific antigen in patients with hypogonadism: effect of testosterone replacementJ Sex Med2005223524016422891
   PubMed Web of Science ®Google Scholar
• RhodenELMorgentalerAInfluence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapyInt J Impot Res20061820120516177827
   PubMed Web of Science ®Google Scholar
• KuhnertBByrneMSimoniMTestosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trialEur J Endocrinol200515331732616061839
   PubMed Web of Science ®Google Scholar
• ParekhDJAnkerstDPHigginsBAExternal validation of the Prostate Cancer Prevention Trial risk calculator in a screened populationUrology2006681152115517169636
   PubMed Web of Science ®Google Scholar
• ThompsonIMAnkerstDPChiCAssessing prostate cancer risk: results from the Prostate Cancer Prevention TrialJ Natl Cancer Inst20069852953416622122
   PubMed Web of Science ®Google Scholar
• ThompsonIMCarrollPRCarducciMARecommendations for defining and treating high risk localized prostate cancerJ Urol2006176S6S1017084170
   PubMed Web of Science ®Google Scholar
• Summary from the second annual andropause consensus meetingChevy Chase, MdEndocrine Society2001
   Google Scholar
• BhasinSSinghABMacRPCarterBLeeMICunninghamGRManaging the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring planJ Androl20032429931112721204
   PubMed Web of Science ®Google Scholar
• RhodenELAverbeckMATelokenPEAndrogen replacement in men undergoing treatment for prostate cancerJ Sex Med2008592202220818638000
   PubMed Web of Science ®Google Scholar
• WestabyDOgleSJParadinasFJRandellJBMurray-LyonIMLiver damage from long-term methyltestosteroneLancet1977226226369876
   PubMed Web of Science ®Google Scholar
• GurakarACaraceniPFagiuoliSVan ThielDHAndrogenic/anabolic steroid-induced intrahepatic cholestasis: a review with four additional case reportsJ Okla State Med Assoc1994873994047996313
   PubMedGoogle Scholar
• SoeKLSoeMGluudCLiver pathology associated with the use of anabolic-androgenic steroidsLiver19921273791535676
   PubMedGoogle Scholar
• BasariaSDobsASRisks versus benefits of testosterone therapy in elderly menDrugs Aging19991513114210495072
   PubMed Web of Science ®Google Scholar
• The Endocrine SocietyClinical bulletins in andropause: benefits and risks of treating hypogonadism in the aging maleEndocr Rep2002216
   Google Scholar
• KimYCTestosterone supplementation in the aging maleInt J Impot Res19991134335210637467
   PubMed Web of Science ®Google Scholar
• ViallardJFMaritGMerciePLengBReiffersJPellegrinJLPolycythaemia as a complication of transdermal testosterone therapyBr J Haematol200011023723810931008
   PubMed Web of Science ®Google Scholar
• DrinkaPJJochenALCuisinierMBloomRRudmanIRudmanDPolycythemia as a complication of testosterone replacement therapy in nursing home men with low testosterone levelsJ Am Geriatr Soc1995438999017636099
   PubMed Web of Science ®Google Scholar
• NieschlagETestosterone treatment comes of age: new options for hypogonadal menClin Endocrinol (Oxf)20066527528116918944
   PubMed Web of Science ®Google Scholar
• UzychLAnabolic-androgenic steroids and psychiatric-related effects: a reviewCan J Psychiatry19923723281551042
   PubMed Web of Science ®Google Scholar
• BahrkeMSYesalisCEIIIWrightJEPsychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males: a reviewSports Med1990103033372263798
   PubMed Web of Science ®Google Scholar
• BagatellCJBremnerWJAndrogens in men – uses and abusesN Engl J Med19963347077148594431
   PubMed Web of Science ®Google Scholar
• World Health OrganizationContraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertilityLancet33695519901977002
   PubMedGoogle Scholar
• World Health OrganizationContraceptive efficacy of testosterone-induced azoospermia and oligozoopermia in normal menFertil Steril1996658218654646
   PubMed Web of Science ®Google Scholar
• WilsonJDAndrogen abuse by athletesEndocr Rev198891811993042375
   PubMed Web of Science ®Google Scholar
• LuboshitzkyRAvivAHefetzAHererPShen-OrrZLavieLLaviePDecreased pituitary-gonadal secretion in men with obstructive sleep apneaJ Clin Endocrinol Metab2002873394339812107256
   PubMed Web of Science ®Google Scholar
• SchneiderBKPickettCKZwillichCWInfluence of testosterone on breathing during sleepJ Appl Physiol1986616186233745052
   PubMed Web of Science ®Google Scholar
• MatsumotoAMSandblomRESchoeneRBTestosterone replacement in hypogonadal men: effects on obstructive sleep apnea, respiratory drives, and sleepClin Endocrinol (Oxf)1985227137214017261
   PubMed Web of Science ®Google Scholar
• von EckardsteinSNieschlagETreatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II studyJ Androl20022341942512002444
   PubMedGoogle Scholar
• TangrediJFBuxtonLLHypertension as a complication of topical testosterone therapyAnn Pharmacother2001351205120711675846
   PubMed Web of Science ®Google Scholar
• de RondeWHyperandrogenism after transfer of topical testosterone gel: case report and review of published and unpublished studiesHum Reprod200924242542818948313
   PubMed Web of Science ®Google Scholar
• CunninghamGRTestosterone replacement therapy for late-onset hypogonadismNat Clin Pract Urol20063526026716691239
   PubMedGoogle Scholar
• CunninghamGRMale hypogonadism: management strategies. News and views on male testosterone deficiencyA Supplement to Renal &Urology News200613
   Google Scholar
• KalyaniRRGaviniSDobsASMale hypogonadism in systemic diseaseEndocrinol Metab Clin North Am200736633334817543722
   PubMed Web of Science ®Google Scholar